Activation of Complement Following Total Hip Replacement

dc.contributor.authorThordardottir, S.
dc.contributor.authorVikingsdottir, T.
dc.contributor.authorBjarnadottir, H.
dc.contributor.authorJonsson, H.
dc.contributor.authorGudbjornsson, B.
dc.contributor.departmentDepartment of Engineering
dc.date.accessioned2026-10-19T14:56:05Z
dc.date.available2026-10-19T14:56:05Z
dc.date.issued2016-03-01
dc.descriptionPublisher Copyright: © 2016 The Foundation for the Scandinavian Journal of Immunology.en
dc.description.abstractThe aim of this study was to investigate whether complement activation, via the classical and alternative pathways, occurs following a cemented total hip replacement (THR) surgery due to osteoarthritis. Blood samples were collected systematically from 12 patients - six male and six women, with a median age of 75 (range: 59-90 years) - preoperatively, 6 h post-operatively and on the first, second and third post-operative day. Total function of classical (CH50) and alternative pathways (AH50) was evaluated, along with the determination of serum concentrations of the complement proteins C3, C4, C3d, the soluble terminal complement complex (sTCC) sC5b-9, as well as C-reactive protein (CRP) and albumin. Measurements of CRP and albumin levels elucidated a marked inflammatory response following the operation. The CH50, AH50 and C3 and C4 levels were significantly lower 6 h after the surgery compared with the preoperative levels, but elevated above the preoperative levels during the following 3 days. The complement activation product C3d levels increased continually during the whole observation period, from 13.5 AU/ml (range: 8-19 AU/ml) preoperative to 20 AU/ml (range: 12-34 AU/ml) on the third post-operative day. Furthermore, we observed an increase in the sC5b-9 levels between the preoperative and the third post-operative day. These results demonstrate a significant activation of the complement system following cemented THR. Further studies are needed to elucidate the time frame and the pathogenic role of this observed complement activation.en
dc.description.versionPeer revieweden
dc.format.extent6
dc.format.extent345762
dc.format.extent219-224
dc.identifier.citationThordardottir, S, Vikingsdottir, T, Bjarnadottir, H, Jonsson, H & Gudbjornsson, B 2016, 'Activation of Complement Following Total Hip Replacement', Scandinavian Journal of Immunology, vol. 83, no. 3, pp. 219-224. https://doi.org/10.1111/sji.12411en
dc.identifier.doi10.1111/sji.12411
dc.identifier.issn0300-9475
dc.identifier.other251400195
dc.identifier.other7ace0caa-2ff0-4085-a2c6-a887916f069f
dc.identifier.other84960131822
dc.identifier.other26725858
dc.identifier.urihttps://hdl.handle.net/20.500.11815/8853
dc.language.isoen
dc.relation.ispartofseriesScandinavian Journal of Immunology; 83(3)en
dc.relation.urlhttps://www.scopus.com/pages/publications/84960131822en
dc.rightsinfo:eu-repo/semantics/openAccessen
dc.subjectImmunologyen
dc.titleActivation of Complement Following Total Hip Replacementen
dc.type/dk/atira/pure/researchoutput/researchoutputtypes/contributiontojournal/articleen

Skrár

Original bundle

Niðurstöður 1 - 1 af 1
Nafn:
Scand_J_Immunol_-_2016_-_Thordardottir_-_Activation_of_Complement_Following_Total_Hip_Replacement.pdf
Stærð:
337.66 KB
Snið:
Adobe Portable Document Format